Purchases and Sales Made in Q3 2023 in Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO) during Q3 2023. The information is specifically focused on institutions that hold shares of Akero Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2023
Q3 2023
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-235K- 39.55% |
$9.68M - $12.3M
|
359K
$18.5M
|
|
|
Nov 14, 2023
Q3 2023
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-245K- 68.06% |
$10.1M - $12.8M
|
115K
$5.92M
|
|
|
Nov 14, 2023
Q3 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-274K- 66.7% |
$11.3M - $14.3M
|
137K
$7.05M
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-282K- 46.01% |
$11.6M - $14.7M
|
331K
$17.1M
|
|
|
Nov 14, 2023
Q3 2023
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-286K- 27.89% |
$11.8M - $14.9M
|
739K
$38.1M
|
|
|
Nov 14, 2023
Q3 2023
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-321K- 16.55% |
$13.2M - $16.8M
|
1.62M
$83.4M
|
|
|
Nov 14, 2023
Q3 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-663K- 71.77% |
$27.3M - $34.6M
|
261K
$13.4M
|
|
|
Nov 14, 2023
Q3 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-1.11M- 36.27% |
$45.6M - $57.8M
|
1.94M
$100M
|
|
|
Nov 14, 2023
Q3 2023
|
Commodore Capital LP
New York, NY |
SELL
|
- |
-1.11M- 66.27% |
$45.7M - $58M
|
565K
$29.1M
|